Metabolic syndrome index measurement tool (MSI): scale development, reliability and validity study
Abstract Aim Identifying the risks of metabolic syndrome (MetS) can lead to early targeted interventions and thus contribute to improved quality of life by reducing the risk of developing MetS, diabetes or heart disease in the future. We aimed to develop a valid and reliable measurement tool to meas...
Saved in:
Main Authors: | Zahide Akeren, Emine Apaydın |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Public Health |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12889-025-21304-7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Obesity, Metabolic Health, and Diabetic Complications in People With Type 1 Diabetes
by: Yuanjie Mao, et al.
Published: (2025-01-01) -
Editorial: Metabolic disorders as risk factors for osteoarthritis and targeted therapies for this pathology
by: Giuseppe Lisco, et al.
Published: (2025-01-01) -
Association between atherogenic index of plasma and future risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3: a nationwide prospective cohort study
by: Gaoshu Zheng, et al.
Published: (2025-01-01) -
Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in 3 Chinese Cohorts
by: Qi Huang, MD, et al.
Published: (2025-01-01) -
Correlation between atherogenic index of plasma and cardiovascular disease risk across Cardiovascular–kidney–metabolic syndrome stages 0–3: a nationwide prospective cohort study
by: Yaohua Hu, et al.
Published: (2025-01-01)